ThreeD Capital (TSE:IDK) has released an update.
ThreeD Capital Inc., a Canadian venture capital firm, has announced a Securities Purchase Agreement with Sariel Diagnostics Corp. to acquire 3.2 million shares, further expanding its portfolio in junior resources and disruptive technologies. The transaction is contingent on approval from the Canadian Securities Exchange and involves the issuance of ThreeD shares at a deemed value.
For further insights into TSE:IDK stock, check out TipRanks’ Stock Analysis page.